☆ 4.6 Article

Evolution of Anti-RBD IgG Avidity following SARS-CoV-2 Infection

VIRUSES-BASEL (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Microbiology

Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses

Alexandra Tauzin et al.

Summary: The study found that extending the interval between doses to 16 weeks significantly increased humoral responses in non-infected individuals, reaching similar levels as previously infected individuals. Compared to a shorter interval, a longer interval between vaccine doses resulted in stronger immune responses.

CELL HOST & MICROBE (2022)

添加到收藏夹

Article Virology

SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells

Shilei Ding et al.

Summary: Using the native full-length Spike protein expressed on the surface of infected cells in serological assays is effective in recapitulating findings and can be recognized by plasma from convalescent and vaccinated individuals.

VIRUSES-BASEL (2022)

添加到收藏夹

Article Cell Biology

A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection

Guillaume Beaudoin-Bussieres et al.

Summary: Emerging evidence suggests that both neutralizing and Fc-mediated effector functions of antibodies are important for protection against SARS-CoV-2. A non-neutralizing antibody, CV3-13, with potent Fc-mediated effector functions, was found to bind to a specific epitope of the SARS-CoV-2 spike from a unique angle. In mouse experiments, the Fc-enhanced version of CV3-13 delayed virus spread, neuroinvasion, and death, and the combination of Fc-enhanced CV3-13 with a neutralizing antibody completely protected mice from lethal SARS-CoV-2 infection.

CELL REPORTS (2022)

添加到收藏夹

Article Cell Biology

SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses

Debashree Chatterjee et al.

Summary: Continuous emergence of SARS-CoV-2 variants of concern (VOCs), such as Omicron, is raising concerns about decreased vaccine efficacy. A study on individuals who received their BNT162b2 mRNA vaccine 16 weeks apart found that a longer interval between doses enhances the recognition and neutralization of Omicron Spike compared to a shorter interval. However, it remains unknown if this difference provides any clinical benefit against Omicron.

CELL REPORTS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Evolution of antibody immunity to SARS-CoV-2

Christian Gaebler et al.

Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination

Alice Cho et al.

Summary: Infection with SARS-CoV-2 leads to evolving B cell responses over at least a year, while vaccination with mRNA vaccines results in high plasma neutralizing activity against various variants. Memory B cells from vaccinated individuals show increased neutralizing activity between prime and boost, but do not exhibit further expansion in potency or breadth.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

Rishi R. Goel et al.

Summary: This study found that immune memory to SARS-CoV-2 and its variants remains robust for at least 6 months after mRNA vaccination, with antibodies declining but still detectable in most individuals. mRNA vaccines also induced functional memory B cells and antigen-specific T cells, with recall responses primarily increasing antibody levels in individuals with preexisting immunity.

SCIENCE (2021)

添加到收藏夹

Article Immunology

Waning of IgG, Total and Neutralizing Antibodies 6 Months Post-Vaccination with BNT162b2 in Healthcare Workers

Jean-Louis Bayart et al.

Summary: Data from this study showed a significant decline in antibodies levels at day 180 post SARS-CoV-2 vaccination, with a more pronounced decrease in neutralizing antibodies. The estimated half-life of IgG was around 21 days in seronegative individuals and 53 days in seropositive individuals, while the half-life of total antibodies ranged from 68 to 114 days. The decline in neutralizing antibodies was particularly stark, with around 45% of subjects testing negative at day 180.

VACCINES (2021)

添加到收藏夹

Article Microbiology

COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions

Opeyemi S. Adeniji et al.

Summary: The study suggests that qualitative differences in SARS-CoV-2-specific antibody-mediated innate immune functions may contribute to COVID-19 severity, with higher ADCD associated with higher inflammation and higher ADCP associated with lower inflammation. Understanding these qualitative features of antibodies could be crucial for developing effective and safe COVID-19 therapeutics and vaccines.

MBIO (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Antibodies and Vaccines Target RBD of SARS-CoV-2

Long Min et al.

Summary: Following the outbreak of the pandemic, the development of neutralizing antibodies and vaccines targeting the coronavirus has become crucial, with RBD being identified as the key research target.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

添加到收藏夹

Article Microbiology

A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses

Alexandra Tauzin et al.

Summary: A single dose of the BNT162b2 mRNA vaccine can be up to 90% effective, with boosted humoral and T cell responses in previously infected individuals. Therefore, spacing doses may help vaccinate more people in conditions of limited vaccine supply.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Immunology

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations

Frauke Muecksch et al.

Summary: This study examined the development of antibodies following infection with the coronavirus, finding that evolved antibodies had increased affinity and neutralization potency, altered mutational pathways for viral resistance, and restricted neutralization escape options. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying populations of the virus and other pandemic threat coronaviruses.

IMMUNITY (2021)

添加到收藏夹

Article Immunology

The unique biology of germinal center B cells

Clara Young et al.

IMMUNITY (2021)

添加到收藏夹

Article Infectious Diseases

Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose

Ilaria Vicenti et al.

Summary: The study found that uninfected healthcare workers had significantly lower neutralizing antibody levels compared to previously infected healthcare workers after vaccination. Additionally, there was a notable decline in neutralizing antibodies among uninfected healthcare workers after vaccination, suggesting the potential benefit of a third vaccine dose.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection

Zijun Wang et al.

Summary: Despite challenges posed by COVID-19 variants, convalescent individuals receiving mRNA vaccines exhibit robust and long-lasting immune responses against circulating SARS-CoV-2 variants, providing hope for effective control of the pandemic.

NATURE (2021)

添加到收藏夹

Article Immunology

Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset

Tiandan Xiang et al.

Summary: One year after infection, most recovered patients still have detectable SARS-CoV-2-specific IgG antibodies, but only a minority have neutralizing activity, especially when facing specific mutated variants. This highlights the importance of vaccinations for individuals who have had a natural infection to protect against emerging variants.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Cell Biology

Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

Sai Priya Anand et al.

Summary: Recent research on convalescent individuals of COVID-19 has shown a decline in antibody levels in plasma, while specific memory B cells remain present. IgM antibodies against Spike and RBD decay rapidly, whereas IgG decline is less significant. Understanding these immune memory responses is crucial for secondary infection prevention and vaccine efficacy.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Xiuyuan Ou et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

添加到收藏夹

Article Microbiology

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals

Guillaume Beaudoin-Bussieres et al.

MBIO (2020)

添加到收藏夹

Article Hematology

Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset

Josee Perreault et al.

BLOOD (2020)

添加到收藏夹

Article Cell Biology

Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike

Jeremie Prevost et al.

CELL REPORTS MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Urea-mediated dissociation alleviate the false-positive Treponema pallidum-specific antibodies detected by ELISA

Qiang Wang et al.

PLOS ONE (2019)

添加到收藏夹

Article Medical Laboratory Technology

Comparison of different enzyme-linked immunosorbent assay methods for avidity determination of antiphospholipid antibodies

Lenka Fialova et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2017)

添加到收藏夹

Review Immunology

Regulation of germinal center B-cell differentiation

Yang Zhang et al.

IMMUNOLOGICAL REVIEWS (2016)

添加到收藏夹

Review Immunology

Dynamics of B cells in germinal centres

Nilushi S. De Silva et al.

NATURE REVIEWS IMMUNOLOGY (2015)

添加到收藏夹

Review Immunology

Germinal Centers

Gabriel D. Victora et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)

添加到收藏夹

Article Immunology

Regulation of memory antibody levels: The role of persisting antigen versus plasma cell life span

Dominique Gatto et al.

JOURNAL OF IMMUNOLOGY (2007)

添加到收藏夹

Article Immunology

Fas is required for clonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire

Y Takahashi et al.

IMMUNITY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.